BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 22257371)

  • 1. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
    Deandreis D; Al Ghuzlan A; Auperin A; Vielh P; Caillou B; Chami L; Lumbroso J; Travagli JP; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2012 Feb; 22(2):165-72. PubMed ID: 22257371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
    World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
    Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
    Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?
    Muñoz Pérez N; Villar del Moral JM; Muros Fuentes MA; López de la Torre M; Arcelus Martínez JI; Becerra Massare P; Esteva Martínez D; Cañadas Garre M; Coll Del Rey E; Bueno Laraño P; Ferrón Orihuela JA
    Langenbecks Arch Surg; 2013 Jun; 398(5):709-16. PubMed ID: 23624819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Merten MM; Castro MR; Zhang J; Durski J; Ryder M
    Thyroid; 2017 Jan; 27(1):95-102. PubMed ID: 27762671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Hales NW; Krempl GA; Medina JE
    Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indeterminate thyroid nodules. The role of
    Piccardo A; Puntoni M; Dezzana M; Bottoni G; Foppiani L; Marugo A; Catrambone U; Ugolini M; Sola S; Gatto M; Treglia G; Giovanella L; Trimboli P
    Endocrine; 2020 Sep; 69(3):553-561. PubMed ID: 32124261
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ciappuccini R; Licaj I; Lasne-Cardon A; Babin E; de Raucourt D; Blanchard D; Bastit V; Saguet-Rysanek V; Lequesne J; Peyronnet D; Grellard JM; Clarisse B; Bardet S
    Thyroid; 2021 May; 31(5):800-809. PubMed ID: 33183159
    [No Abstract]   [Full Text] [Related]  

  • 9. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS; Choi Y; Kim EK; Yoon JH; Youk JH; Han KH; Moon HJ; Kang WJ; Kwak JY
    Ultraschall Med; 2014 Feb; 35(1):51-8. PubMed ID: 24458573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
    Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
    Batawil N; Alkordy T
    Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
    Nguyen TT; Lange NGE; Nielsen AL; Thomassen A; Døssing H; Godballe C; Rohde M
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2109-2117. PubMed ID: 29909471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Diagnostics and [
    de Koster EJ; Morreau H; Bleumink GS; van Engen-van Grunsven ACH; de Geus-Oei LF; Links TP; Wakelkamp IMMJ; Oyen WJG; Vriens D
    Thyroid; 2024 Jan; 34(1):41-53. PubMed ID: 38009209
    [No Abstract]   [Full Text] [Related]  

  • 16. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound stratification of the FDG-avid thyroid nodule.
    Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
    Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
    Giovanella L; Suriano S; Maffioli M; Ceriani L
    Clin Endocrinol (Oxf); 2011 May; 74(5):644-8. PubMed ID: 21470288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative classification and radiomics of [
    de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.